Deicher H R, Drenk F, Hoffman G
Abt. Immunologie und Transfusionsmedizin, Medizinische Hochschule Hannover, FRG.
Z Rheumatol. 1987 Jul-Aug;46(4):196-7.
A low molecular weight LtB4-carrier complex has been identified as endothelial cytotoxic activity (ECA) in progressive systemic sclerosis (PSS) patients' sera. ECA is thought to play a key role in the initiation of obliterative vasculopathy, a basic tissue lesion of this disease.
一种低分子量白三烯B4载体复合物已被确定为进行性系统性硬化症(PSS)患者血清中的内皮细胞毒性活性(ECA)。ECA被认为在闭塞性血管病的起始过程中起关键作用,闭塞性血管病是该疾病的一种基本组织病变。